Videos

Metabolic-Pathway-Targeting Medication Options for NAFLD

07/02/2020

In this video, Arun Sanyal, MD, talks about the treatment options that are available for treating nonalcoholic fatty liver disease via metabolic pathways. He recently spoke about this topic at the 21st Annual Harvard Nutrition and Obesity Symposium on NAFLD. Read the full transcript here.

Arun Sanyal, MD, is a professor of medicine at Virginia Commonwealth University in Richmond, Virginia.

For more coverage of the symposium, visit our Resource Center.

Sign up for our e-Newsletters

Gastroenterology Newsletter

News

Colorectal Cancer Screening Effective for Patients Aged 45 to 50 Years

11/18/2024

Riya Gandhi , MA;

New study supports earlier colorectal cancer screening, showing similar completion and yield rates for those aged 45 to 49 as for those aged 50.

New study supports earlier...

11/18/2024

Gastroenterology

News

Colonoscopy After Diverticulitis Usually Unnecessary

11/14/2024

In colonoscopies performed solely for diverticulitis, the CRC prevalence was just 0.17%, the study found.

In colonoscopies performed...

11/14/2024

Gastroenterology

News

Upper Gl Mucosal Damage Associated With Parkinson's Disease

10/18/2024

Jessica Garlewicz ;

Upper gastrointestinal (GI) mucosal damage was associated with elevated risk of developing Parkinson's disease.

Upper gastrointestinal (GI)...

10/18/2024

Gastroenterology

News

Vonoprozan Compared to PPIs for Peptic Ulcer Rebleeding Prevention

10/18/2024

Jessica Garlewicz ;

Vonoprazan offers an effective alternative treatment to intravenous proton pump inhibitors for prevention of rebleeding among patients with high-risk peptic ulcers, researchers found.

Vonoprazan offers an effective...

10/18/2024

Gastroenterology

News

NAFLD or MASLD? Research Looks at Concordance of Criteria

10/18/2024

Jessica Garlewicz ;

New nomenclature shows strong applicability in real-world clinical settings.

New nomenclature shows strong...

10/18/2024

Gastroenterology

News

Liver Histology Impact on Long-Term Clinical Outcomes in MASH

10/18/2024

Rebecca Mashaw ;

Results showed that a lower fibrosis stage (F0–1) was associated with a significantly reduced risk of cirrhosis and liver-related outcomes compared to patients with advanced fibrosis (F4).

Results showed that a lower...

10/18/2024

Gastroenterology

News

AI-Enabled Electrocardiogram Shows Promise in Predicting MASLD

10/18/2024

Jessica Garlewicz ;

Researchers explored the use of an artificial intelligence model to detect metabolic dysfunction–associated steatotic liver disease.

Researchers explored the use of...

10/18/2024

Gastroenterology

News